Version 1
: Received: 18 July 2024 / Approved: 19 July 2024 / Online: 19 July 2024 (10:59:56 CEST)
How to cite:
Piccin, A.; Hervig, T.; Allameddine, A.; Spizzo, G.; Lappin, K. M.; Prati, D. Platelet Pathogen Reduction Technology. Should We Stay or Should We Go…?. Preprints2024, 2024071600. https://doi.org/10.20944/preprints202407.1600.v1
Piccin, A.; Hervig, T.; Allameddine, A.; Spizzo, G.; Lappin, K. M.; Prati, D. Platelet Pathogen Reduction Technology. Should We Stay or Should We Go…?. Preprints 2024, 2024071600. https://doi.org/10.20944/preprints202407.1600.v1
Piccin, A.; Hervig, T.; Allameddine, A.; Spizzo, G.; Lappin, K. M.; Prati, D. Platelet Pathogen Reduction Technology. Should We Stay or Should We Go…?. Preprints2024, 2024071600. https://doi.org/10.20944/preprints202407.1600.v1
APA Style
Piccin, A., Hervig, T., Allameddine, A., Spizzo, G., Lappin, K. M., & Prati, D. (2024). Platelet Pathogen Reduction Technology. Should We Stay or Should We Go…?. Preprints. https://doi.org/10.20944/preprints202407.1600.v1
Chicago/Turabian Style
Piccin, A., Katrina M. Lappin and Daniele Prati. 2024 "Platelet Pathogen Reduction Technology. Should We Stay or Should We Go…?" Preprints. https://doi.org/10.20944/preprints202407.1600.v1
Abstract
The recent COVID-19 pandemic has significantly challenged Blood Transfusion Services (BTS) for providing blood products and for keeping blood supplies available. The possibility that similar pandemic event may occur again has induced researchers and transfusionists to investigate the adoption of new tools to prevent and reduce these risks. Similarly, increased donor travelling and globalization, with consequent donor-deferral and donor pool reduction, have contributed to raise awareness on this topic. Although recent studies have validated the use of pathogen reduction technology (PRT) for the control of Transfusion Transmitted Infections (TTI) this method is not a standard of care despite increasing adoption. We present a critical commentary on the role of PRT for platelet and on associated problems for blood transfusion services (BTS). The balance of cost effectiveness of adopting PRT is also discussed.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
